Navigation Links
Access Pharmaceuticals Signs Agreement for CobaCyte® and CobOral® in RNAi Therapeutic Delivery
Date:11/8/2011

of this vitamin.  In many diseases, the demand for vitamin B12 is increased, with a corresponding upregulation of the receptor. Using the 'Trojan Horse' principle, the CobaCyte nanoparticle technology can utilize the vitamin B12 uptake mechanism to transport siRNA into cells whereupon native siRNA can be released for incorporation in messenger RNA (mRNA) to initiate the beneficial therapeutic effect. In this way, CobaCyte offers the potential for targeted delivery of siRNA following intravenous administration. The fact that Access' vitamin B12 technology also facilitates oral drug delivery (the CobOral technology) indicates that it may also be possible for this technology to provide effective siRNA treatments by oral drug delivery.

About Access:Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products include MuGard™ (www.MuGard.com), which has received FDA marketing clearance for the management of patients with mucositis, ProLindac™, a second generation DACH Platinum in Phase 2 clinical testing of patients with ovarian cancer, and Thiarabine™, a novel nucleoside analog that has demonstrated both pre-clinical and clinical activity in certain cancers; currently in a Phase 1/2a trial in hematological malignancies at M.D. Anderson Cancer Center in Houston, Texas.  

The company also has other advanced drug delivery technologies including CobaCyte™-mediated targeted delivery and CobOral-oral
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Access Medical Laboratories, Inc. to Celebrate Grand Opening of New Laboratory Headquarters in Jupiter, Florida
2. Full Agenda Announced for CMAC 2011 - CBIS 2nd Annual Commercialization and Market Access Congress
3. Crucial Directives Must be Revised to Protect Patients Interests and Improve Access to Treatment
4. New Partnership Bolsters Relivs Access to Plant Biotech Research
5. Insmed to Present at 2011 Wedbush Securities Life Sciences Management Access Conference
6. Interleukin Genetics, Inc. to Present at the 2011 Wedbush Securities Life Sciences Management Access Conference
7. Accuray Incorporated to Speak at 2011 Wedbush Life Sciences: Management Access Conference
8. Arthrosurface Launches Worlds First Easy Access Glenoid Resurfacing System
9. TALEN® Access by Cellectis Bioresearch Receives "Most Innovative New Service 2011" Award at Life Science Awards
10. MedeAnalytics Launches Patient Access Resource Center
11. Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Nov. 18, 2014  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... cells) for complete cervical spinal cord injury (SCI), ... Advanced Therapies Projects to Watch" by Elsevier Business ... this significant industry honor, which represents independent validation ...
(Date:11/18/2014)... Pa. , Nov. 18, 2014  Novira Therapeutics, ... for curative treatment of chronic hepatitis B virus (HBV) ... M.D., was appointed to its Scientific Advisory Board (SAB).  ... join our SAB," said Christian S. Schade , ... of clinical development experience which will be invaluable to ...
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today the formation of a Medical ... to the Company as it advances the Phase ... the treatment of cutaneous T-cell lymphoma (CTCL), a ...
(Date:11/16/2014)... November 16, 2014 James Hill and ... Filtered Fume Hoods, 3 Years Later” scheduled for Thursday, ... of 2011, Butler University surprised many in the lab ... their organic chemistry and general chemistry teaching laboratories at ... to building age and substantial growth within the chemistry ...
Breaking Biology Technology:Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 2Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 3
... Marketing in the United States, Trade Name Will be ... ... Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY ) ... (NDA) for prasugrel to the U.S. Food and Drug Administration,(FDA). Prasugrel is ...
... Calif., Jan. 4 Thermage, Inc.,(Nasdaq: THRM ... the aesthetic,industry, announced today that it will present ... at The Palace Hotel in New York City. ... 2008 at 11:00,a.m. Eastern Time. Stephen J. Fanning, ...
... 2007) -- In the face of terrorism and catastrophic ... for critically injured patients are more vital than ever. ... systems -- such as the notion that it is ... first -- have rarely been subjected to rigorous scientific ...
Cached Biology Technology:Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 2Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 3Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 4Triage study challenges notions of emergency medical response to disaster 2Triage study challenges notions of emergency medical response to disaster 3Triage study challenges notions of emergency medical response to disaster 4
(Date:11/7/2014)... Calif. , Nov. 7, 2014  In conjunction with ... Police Departments, The Community Foundation of the Verdugos ... DNA JUSTICE PROJECT," a $250,000 initiative to keep ... initial phase. In its first six months of existence, the ... needed evidence support for local law enforcement. "Because ...
(Date:11/6/2014)... of metastasis, yet progress in preventing and treating ... been particularly challenging to design drugs that work ... systems biology at Harvard Medical School. , ... already metastasized." , Gujral and colleagues have now ... better understand how metastasis begins. Their findings may ...
(Date:11/5/2014)... Fidel Santamaria, associate professor of biology in the ... researchers in the nation selected to receive a ... Grant for Exploratory Research (EAGER). The funding supports ... support researchers to create new technology that will ... Santamaria, complex behaviors in neuroscience are broken into ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Migration negation 2Migration negation 3UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3
... MA For those living with gastrointestinal disorders, such as ... through medications or dietary changes. But what if one day ... new gut free of inflamed or diseased tissues? ... and Massachusetts Institute of Technology (MIT) are hoping their new ...
... short article and photography competition were announced at an ... winning essay, by Laura Hepburn of the University of ... recent research voyage when she first saw underwater hydrothermal ... screens. These are underwater fissures that erupt volcanic gasses ...
... Switzerland)--Organizers of the 20th International AIDS Conference (AIDS 2014) ... 2014 today announced 19 major plenary presentations, focusing on ... AIDS. Plenary sessions will open each day of the conference, ... from over 200 countries. "We are excited to ...
Cached Biology News:Manufacturing a new gut to treat GI diseases 2NERC announces the winner of its first photo and essay competition 2NERC announces the winner of its first photo and essay competition 320th International AIDS Conference (AIDS 2014) plenary speakers announced 220th International AIDS Conference (AIDS 2014) plenary speakers announced 3
Immulon 1 B 1x12 Strip, flat bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
...
Small bottle for hybridization 150 x 35mm...
Biology Products: